Viagra
Product Images NDC 50090-0619

11 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Viagra (NDC 50090-0619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900619)

Label Image (Lbl500900619)
Viagra 100 mg tablet label from A-S Medication Solutions, showing the lot number and storage instructions to keep at 77 degrees Fahrenheit. The label states that each tablet contains sildenafil citrate equivalent to 100 mg sildenafil, with a package size of 4 tablets. The labeler is identified as A-S Medication Solutions in Libertyville, Illinois.*
FDA Label Image

Chemical Structure (Viagra 01)

FDA Label Image

Figure 1 (Viagra 02)

Figure 1 (Viagra 02)
Line graph depicting changes in systolic blood pressure (mmHg) over 24 hours post dose. The x-axis shows time post dose in hours, and the y-axis shows systolic blood pressure changes. Two lines compare data for Sildenafil 100 mg and placebo groups.*
FDA Label Image

Figure 2 (Viagra 03)

Figure 2 (Viagra 03)
Line chart showing change in seated systolic blood pressure (SBP) over 8 hours postdose. The graph compares three groups: Doxazosin, Doxazosin + Sildenafil 25 mg, and Placebo, with the x-axis representing time in hours and the y-axis representing change in SBP in mmHg.*
FDA Label Image

Figure 3 (Viagra 04)

Figure 3 (Viagra 04)
A line graph comparing change in systolic blood pressure (SBP) over time postdose in hours for three groups: Doxazosin + Placebo, Doxazosin + Sildenafil 50 mg, and a control group. The x-axis represents time in hours up to 8 hours, and the y-axis represents the change in SBP in mmHg, ranging from -50 to 40 mmHg.*
FDA Label Image

Figure 4 (Viagra 05)

Figure 4 (Viagra 05)
A line graph comparing changes in mmHg over time after dosing for two groups: Doxazosin plus Sildenafil 100 mg and Doxazosin plus Placebo. The x-axis shows time after dosing in hours (0 to 8), and the y-axis shows mmHg values from -50 to 40. The graph illustrates the blood pressure response trends for both treatment combinations over the 8-hour period.*
FDA Label Image

Figure 5 (Viagra 06)

Figure 5 (Viagra 06)
A pharmacokinetic curve showing plasma concentration (ng/mL) of the active ingredient over 24 hours after a single dose of Viagra commercial tablet. The graph depicts a peak concentration early after dosing followed by a gradual decline to near baseline levels by 24 hours.*
FDA Label Image

Figure 6 (Viagra 07)

Figure 6 (Viagra 07)
Bar chart titled 'Effect of VIAGRA on Maintenance of Erection by Baseline Score' showing percentage of patients at endpoint on the y-axis and baseline score on the x-axis. The chart compares different baseline scores (0 to 5) with various values represented by shaded bars, illustrating patient response distribution.*
FDA Label Image

Figure 6 (Viagra 08)

Figure 6 (Viagra 08)
A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score.' The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients at endpoint, ranging from 0 to 80%. Multiple bars for each baseline score correspond to different data categories labeled 0 through 5 in the legend.*
FDA Label Image

Figure 7 (Viagra 09)

Figure 7 (Viagra 09)
A bar chart showing the percentage of patients reporting improvement across different treatment groups. The groups compared are Placebo, Viagra 25 mg, Viagra 50 mg, and Viagra 100 mg, with improvement percentages of 24%, 63%, 74%, and 82%, respectively.*
FDA Label Image

Logo (Viagra 10)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.